Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry

The benefits and use of low-dose corticosteroids (LDCs) in severe sepsis and septic shock remain controversial. Surviving sepsis campaign guidelines suggest LDC use for septic shock patients poorly responsive to fluid resuscitation and vasopressor therapy. Their use is suspected to be wide-spread, b...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care (London, England) England), 2010-01, Vol.14 (3), p.R102-R102, Article R102
Hauptverfasser:	Beale, Richard, Janes, Jonathan M, Brunkhorst, Frank M, Dobb, Geoffrey, Levy, Mitchell M, Martin, Greg S, Ramsay, Graham, Silva, Eliezer, Sprung, Charles L, Vallet, Benoit, Vincent, Jean-Louis, Costigan, Timothy M, Leishman, Amy G, Williams, Mark D, Reinhart, Konrad
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - administration & dosage Adrenal Cortex Hormones - pharmacology Adrenal Cortex Hormones - therapeutic use Adult Aged Corticosteroids Dosage and administration Dose-Response Relationship, Drug Drug therapy Humans Intensive Care Units Middle Aged Patient outcomes Practice Patterns, Physicians' - statistics & numerical data Propensity Score Prospective Studies Registries Sepsis Septic shock Shock, Septic - drug therapy Shock, Septic - mortality Treatment Outcome Vasoconstrictor Agents - administration & dosage Vasoconstrictor Agents - pharmacology Vasoconstrictor Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!